Related Experiment Videos
Pharmacotherapy for treatment-resistant schizophrenia
Meghan E McIlwain1, Jeff Harrison, Amanda J Wheeler
1School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;
Neuropsychiatric Disease and Treatment
|May 10, 2011
Summary
Effective treatment strategies are needed for individuals with treatment-resistant schizophrenia. This review examines recent evidence for managing patients who do not respond to standard antipsychotics or clozapine.
Area of Science:
- Psychiatry and Neuroscience
- Pharmacology
Background:
- Schizophrenia affects 0.7% globally, causing severe social and occupational impairment.
- Many patients experience suboptimal response to antipsychotics, particularly for negative symptoms.
- Treatment resistance is common, necessitating advanced therapeutic strategies.
Purpose of the Study:
- To review recent evidence on treatment strategies for schizophrenia.
- To address patients with treatment resistance to non-clozapine antipsychotics.
- To explore options for patients with partial or no response to clozapine.
Main Methods:
- Literature review of recent studies.
- Analysis of treatment efficacy and adverse effects.
- Focus on evidence for nonclozapine and clozapine-resistant populations.
Main Results:
- Clozapine shows superior efficacy in treatment-resistant schizophrenia but has significant adverse effects.
- Only 30-50% of patients achieve significant improvement with clozapine.
- Evidence for alternative strategies in non-responders is crucial.
Conclusions:
- Effective management of treatment-resistant schizophrenia requires exploring options beyond initial antipsychotic trials.
- Balancing efficacy with safety is critical when considering clozapine and alternative treatments.
- Further research is needed for optimizing care in refractory schizophrenia cases.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...